Test Price
2,800 AED✅ Home Collection Available
CACNA1C Gene Brugada Syndrome Type 3 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين CACNA1C لمتلازمة بروغادا من النوع 3 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي
- دقة تشخيصية 99.9% – 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- خدمة منزلية متميزة – Hospital‑Grade Home Collection with ISO‑Certified Cold‑Chain Logistics & VIP Mobile Phlebotomy (8 AM‑11 PM).
- استشارة طبية بعد الفحص – Telephonic Post‑Test Clinical Guidance for result interpretation by a DHA‑licensed genetic counsellor.
- تأمين معتمد – Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
The CACNA1C Gene Brugada Syndrome Type 3 NGS Test uses Next‑Generation Sequencing to detect pathogenic variants in the CACNA1C gene, the definitive molecular diagnosis for Brugada syndrome type 3—an inherited channelopathy predisposing to life‑threatening ventricular arrhythmias. يكشف هذا التحليل الطفرات الجينية المسببة لمتلازمة بروغادا من النوع 3 بدقة متناهية.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% sensitivity, full gene coverage | ~95% sensitivity, limited to known hotspots |
| Methodology | ISO 9001:2015‑certified NGS (Illumina platform) | Capillary electrophoresis, non‑ISO lab |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
Expert Clinical Insight & Safety Protocol
“A positive CACNA1C variant confirms a molecular predisposition, yet clinical correlation with 12‑lead ECG, Holter monitoring, and family history is indispensable. This test empowers risk stratification but never replaces a cardiologist’s comprehensive evaluation. I urge every patient to discuss results promptly with their electrophysiologist.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011
⚠️ Medication Warning: Do not discontinue or adjust any prescribed cardiac medications without explicit instruction from your treating physician. Abrupt cessation of antiarrhythmics or beta‑blockers may provoke dangerous arrhythmias.
Safety Exclusion Criteria
- Acute febrile illness or recent blood transfusion (within 4 weeks)
- Known hematological malignancy interfering with DNA extraction
- Inability to provide informed consent (legal guardian required for minors per UAE CDS Law 2026)
Emergency Red Flags – Seek immediate care if:
- Syncope (fainting), seizures, or nocturnal agonal respiration
- Palpitations with chest discomfort or dyspnoea
- Family history of sudden unexplained death below age 40
Frequently Asked Questions
1. What exactly does the CACNA1C gene test detect?
Snippet: This genetic test detects CACNA1C mutations causing Brugada syndrome type 3, a serious arrhythmia disorder.
It sequences the entire CACNA1C gene, identifying single nucleotide variants, small indels, and copy number changes linked to Brugada syndrome type 3. A positive result confirms the molecular diagnosis and enables family cascade screening, while a negative result reduces but does not eliminate clinical suspicion—clinical ECG criteria remain paramount.
يكشف هذا الاختبار الجيني عن طفرات في جين CACNA1C تسبب متلازمة بروغادا من النوع 3، وهو اضطراب نظم قلبي خطير.
2. How should I prepare for the blood collection at home?
Snippet: No fasting or medication changes are required; a simple blood draw is all that’s needed.
Our DHA‑licensed mobile phlebotomist visits your location within 8 AM‑11 PM using an ISO‑certified cold‑chain kit. You only need to provide a signed consent form and clinical history questionnaire. Anticoagulant use does not preclude testing, but please inform the phlebotomist beforehand. Genetic counselling is integrated into the pre‑test consultation at no extra charge.
لا يشترط الصيام أو تغيير الأدوية؛ يكفي سحب عينة دم بسيطة بواسطة ممرض مرخص من هيئة الصحة.
3. Will insurance cover this genetic in the UAE?
Snippet: Most UAE insurers cover genetic testing for Brugada syndrome when medically justified with prior authorization.
We provide direct billing verification via WhatsApp at +971 54 548 8731. Coverage depends on your plan’s genetic testing clause; our team assists with pre‑authorization by submitting the cardiologist’s referral and clinical notes. Under UAE PDPL, all genetic data is stored securely with patient‑only access.
تغطي معظم شركات التأمين في الإمارات الفحص الجيني لمتلازمة بروغادا عند وجود مبرر طبي وموافقة مسبقة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians